PYCR1 and lung adenocarcinoma: When treating lung adenocarcinoma cells with cisplatin in PYCR1-silenced/vehicle control/blank control groups, cisplatin stimulation significantly increased cell proliferation in PYCR1-silenced group when compared to the vehicle control.